Skip to main content
U.S. flag

An official website of the United States government

Return to Search

Seasonal Influenza Vaccines Pricing

Guidance for payment allowances and effective dates for influenza vaccines.

Issued by: Centers for Medicare & Medicaid Services (CMS)

Issue Date: August 26, 2020

The Medicare Part B payment allowance limits for seasonal influenza (flu) vaccines are 95% of the Average Wholesale Price (AWP), as reflected in the published compendia.

In hospital outpatient departments, payment is based on reasonable cost.

Annual Part B deductible and coinsurance amounts don’t apply for the influenza virus vaccinations. All physicians, non-physician practitioners, and suppliers who administer these vaccinations must take assignment on the claim for the vaccine.

Annual Influenza Vaccine season starts on August 1 and ends on July 31 of the following year.
 

Payment Allowances and Effective Dates by Flu Season

2022-2023

Payment Allowances and Effective Dates for the 2022-2023 Flu Season:

CodeLabeler NameVaccine NamePayment AllowanceEffective Dates
90662Sanofi PasteurFluzone High-Dose Quadrivalent (2022/2023)$ 69.94108/01/2022 – 07/31/2023
90672MedImmuneFluMist Quadrivalent (2022/2023)$ 26.87608/01/2022 – 07/31/2023
90674SeqirusFlucelvax Quadrivalent (2022/2023) (Preservative Free)$ 32.27808/01/2022 – 07/31/2023
90682Sanofi PasteurFlublok Quadrivalent (2022/2023) (Preservative Free)$ 69.94108/01/2022 – 07/31/2023
90686

GlaxoSmithKline

Sanofi Pasteur

Seqirus

Fluarix Quadrivalent (2022/2023) (Preservative Free)
Flulaval Quadrivalent (2022/2023) (Preservative Free)
Fluzone Quadrivalent (2022/2023) (Preservative Free)
Afluria Quadrivalent (2022/2023) (Preservative Free)
$ 21.51808/01/2022 – 07/31/2023
90687

Sanofi Pasteur

Seqirus

Fluzone Quadrivalent 0.25ml (2022/2023)
Afluria Quadrivalent 0.25ml (2022/2023)
$ 10.24108/01/2022 – 07/31/2023
90688

Sanofi Pasteur

Seqirus

Fluzone Quadrivalent (2022/2023)
Afluria Quadrivalent (2022/2023)
$ 20.48208/01/2022 – 07/31/2023
90694SeqirusFluad Quadrivalent (2022/2023) (Preservative Free)$ 71.68208/01/2022 – 07/31/2023
90756SeqirusFlucelvax Quadrivalent (2022/2023)$ 30.58108/01/2022 – 07/31/2023

Payment limits and effective dates for newly approved and marketed influenza vaccines will be posted to this webpage.

2021 - 2022

Payment Allowances and Effective Dates for the 2021-2022 Flu Season:

Code

Labeler Name

Vaccine Name

Payment Allowance

Effective Dates

90662

Sanofi Pasteur

Fluzone High-Dose Quadrivalent (2021/2022)

 $65.261

08/01/2021 – 07/31/2022

90672

MedImmune

FluMist Quadrivalent (2021/2022)

 $26.876

08/26/2021 – 07/31/2022

90674

Seqirus

Flucelvax Quadrivalent (2021/2022) (Pres Free)

 $29.940

08/11/2021 – 07/31/2022

90682

Sanofi Pasteur

Flublok Quadrivalent (2021/2022)

 $65.261

 

08/01/2021 – 07/31/2022

90685

Sanofi Pasteur

Seqirus

Fluzone Quadrivalent 0.25ml  (2021/2022) (Pres Free)

Afluria Quadrivalent 0.25ml (2021/2022) (Pres Free)

 $21.639

08/01/2021 – 07/31/2022

90686

GlaxoSmithKline

Sanofi Pasteur

Seqirus

Fluarix Quadrivalent (2021/2022) (Pres free)

Flulaval Quadrivalent (2021/2022) (Pres Free)

Fluzone Quadrivalent  (2021/2022) (Pres Free)

Afluria Quadrivalent (2021/2022) (Pres Free)

 $20.526

08/01/2021 – 07/31/2022

90687

Sanofi Pasteur

Seqirus

Fluzone Quadrivalent  0.25ml (2021/2022)

Afluria Quadrivalent 0.25ml (2021/2022)

 $9.953

08/01/2021 – 07/31/2022

90688

Sanofi Pasteur

Seqirus

Fluzone Quadrivalent (2021/2022)

Afluria Quadrivalent (2021/2022)

 $19.906

08/01/2021 – 07/31/2022

90694

Seqirus

Fluad Quadrivalent (2021/2022)

 $66.426

08/11/2021 – 07/31/2022

90756

Seqirus

Flucelvax Quadrivalent (2021/2022)

 $28.370

08/11/2021 – 07/31/2022


Payment limits and effective dates for newly approved and marketed influenza vaccines will be posted to this webpage.
 

2020 - 2021

Payment Allowances and Effective Dates for the 2020-2021 Flu Season:

Code

Labeler Name

Vaccine Name

Payment Allowance

Effective Dates

90653

Seqirus

Fluad (2020/2021)

 $59.529

8/01/2020 – 07/31/2021

90694

Seqirus

Fluad Quadrivalent (2020/2021)

 $61.000

8/01/2020 – 07/31/2021

90662

Sanofi Pasteur

Fluzone High-Dose Quadrivalent (2020/2021)

 $ 60.982

8/05/2020 – 07/31/2021

90672

MedImmune

FluMist Quadrivalent (2020/2021)

 $26.876

8/12/2020 – 07/31/2021

90674

Seqirus

Flucelvax Quadrivalent (2020/2021) (Pres Free)

 $29.228

8/06/2020 – 07/31/2021

90682

Sanofi Pasteur

Flublok Quadrivalent (2020/2021)

 $60.982

 

8/01/2020 – 07/31/2021

90685

Sanofi Pasteur

Seqirus

Fluzone Quadrivalent 0.25ml  (2020/2021) (Pres Free)

Afluria Quadrivalent 0.25ml (2020/2021) (Pres Free)

 $21.129

8/01/2020 – 07/31/2021

90686

GlaxoSmithKline

Sanofi Pasteur

Seqirus

Fluarix Quadrivalent (2020/2021) (Pres free)

Flulaval Quadrivalent (2020/2021) (Pres Free)

Fluzone Quadrivalent  (2020/2021) (Pres Free)

Afluria Quadrivalent (2020/2021) (Pres Free)

 $19.581

08/01/2020 – 07/31/2021

90687

Sanofi Pasteur

Seqirus

Fluzone Quadrivalent  0.25ml (2020/2021)

Afluria Quadrivalent 0.25ml (2020/2021)

 $9.584

8/01/2020 – 07/31/2021

90688

Sanofi Pasteur

Seqirus

Fluzone Quadrivalent (2020/2021)

Afluria Quadrivalent (2020/2021)

 $19.168

8/01/2020 – 07/31/2021

90756

Seqirus

Flucelvax Quadrivalent (2020/2021)

 $27.695

8/06/2020 – 07/31/2021

Payment limits and effective dates for newly approved and marketed influenza vaccines will be posted to this webpage.

During the flu season, if the FDA approves new vaccines, we’ll update our pricing table.


Get more information on frequency & coverage, coding, and billing. 
 

HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.

DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.